Novel Curcumin Derivative-Decorated Ultralong-Circulating Paclitaxel Nanoparticles: A Novel Delivery System with Superior Anticancer Efficacy and Safety

PURPOSE: Paclitaxel (PTX) has been widely utilized for the treatment of breast cancer. However, drawbacks, such as poor aqueous solubility, rapid blood clearance and severe toxicity, greatly reduce its efficacy and safety. Herein, a novel self-developed curcumin derivative (CUD) was chosen as the ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yumeng, Zeng, Mingtang, Pi, Chao, Shen, Hongping, Yuan, Jiyuan, Zuo, Ying, Wen, Jie, Guo, Pu, Zhao, Wenmei, Li, Ke, Su, Zhilian, Song, Xinjie, Fu, Shaozhi, Lee, Robert J, Zhao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673813/
https://www.ncbi.nlm.nih.gov/pubmed/36406640
http://dx.doi.org/10.2147/IJN.S369761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673813/
https://www.ncbi.nlm.nih.gov/pubmed/36406640
http://dx.doi.org/10.2147/IJN.S369761

Ejemplares similares